Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Intro highlights steps to build credit with a secured card while avoiding debt, emphasizing payment discipline and utilization management.
22,663 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Asana's 2026 earnings outlook blends strong ARR growth with improving efficiency. This guide breaks down the key numb...
Wix.com (WIX) 2025 earnings offer a window into how a diversified website builder navigates growth, margins, and mone...
A fresh take on a notable portfolio move: Kettle Hill Capital reveals a sizable Braze stake via a 747,715-share initi...
As regulators eye crypto privacy tools, the DOJ's push for an October retrial in the Tornado Cash case tests how far ...
March 2026 brings a crowded field of Seeking Alpha alternatives. Traders now weigh real-time data, crowd insights, an...
Former Indeed CEO Chris Hyams argues the real AI danger comes from the people steering the technology, not the code. ...
A well-known AI stock has retraced roughly a quarter from its high, creating a potential entry point for investors. T...
Investors eye defense names as budget cycles shape returns. This guide compares Lockheed Martin and RTX, breaking dow...
The post-IPO market is buzzing about Swarmer, but excitement can blur judgment. Here are three practical realities ev...
When AI dominates headlines, investors often fear every software stock will crumble. This piece digs into whether fig...
Rishi Sunak pressed corporate leaders to accelerate AI projects, warning that slow adoption could widen gaps between ...